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In this investigation, the genotoxic properties of  mestranol were examined in vitro. 
Human lymphocyte cultures were exposed for 72 h to mestranol at concentrations 
of  7.5, 15 and 30 µg/g. The genotoxic effects of  the chemosterilant were assessed by 
numerical and structural chromosome aberrations.
Mestranol induced certain genotoxic effects in human lymphocytes. There was a 
dose-dependent signifi cant (p<0.01) increase in the number of  numerical aberrations 
in comparison to the control, but without signifi cant differences (p>0.05) between 
the doses applied. Further, structural aberrations increased signifi cantly (p<0.01) in 
the presence of  mestranol, being most frequent in cultures exposed to the highest 
mestranol dose.
The frequency of  Robertsonian translocations increased signifi cantly only in cultures 
treated with mestranol at concentration of  30 µg/g in comparison both with the control 
(p<0.01) and the lowest chemosterilant dose (p<0.01).
There were signifi cant differences (p<0.01) in the levels of  chromosome gaps and 
fragments compared to Robertsonian translocations, whilst the frequencies between 
gaps and fragments were not signifi cantly different (p>0.05).
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INTRODUCTION
The number of  mouse-like rodent populations has been growing continuously during 
evolution and accordingly and caused damages infl icted to humans directly or indirectly. 
Owing to the obvious economic and epidemiological/epizootiological importance 
of  rodents, it is necessary to carry out a systematic rodent control, which means to 
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reduce the populations of  harmful rodents to tolerable levels, all of  which is aimed at 
preserving the health of  people, domestic animals and game, as well as tangible assets. 
The use of  mechanical, physical, biological and chemical means of  combat against 
mouse-like rodents has not lead to satisfactory results, that is, satisfactory results can 
be achieved in small buildings or in larger on condition they are not heavily invaded.
Given the growing emergence of  resistance of  rodents to rodenticides, [1] there is a 
necessity to produce novel methods, or novel chemical compounds in order to fi ght 
and regulate the populations of  mouse-like rodents. One of  the products, available on 
the market, are ready-to-use baits based on chemosterilants (mestranol). The mode of  
action of  chemosterilants is based on their ability to lead to temporary or permanent 
sterility of  males or females only, or both genders of  harmful rodents. They may 
directly or indirectly impair the development or maturation of  gametes prior to or 
after copulation, prevent the fusion of  the egg cell and the sperm cell and, fi nally, the 
implantation of  the fertilized ovum in the uterus [2]. Further, they can suppress the 
sexual development of  the offspring and cause irreversible infertility, cause death in 
the offspring due to the decrease in maternal lactation [3].
Given that it has been confi rmed that some pesticides [4,5] especially rodenticides, 
mainly based on coumarin and indandione, [6-11] may cause cytological and mitotic 
changes, and chromosomal aberrations, and that there are scarce data on the genotoxic 
effects of  chemosterilants, it has been decided that in this work we focus on the 
possible genotoxic effects of  mestranol on human lymphocytes in vitro.
MATERIAL AND METHODS
The genotoxic effects of  mestranol (17-α-ethynylestradiole-3-methyl ether), a powerful 
chemosterilant, were assessed in vitro.
Mestranol is a steroid chaemosterilant. Its effects include the inhibition of  ovulation, 
prevention and disruption of  implantation, the absorption of  the embryo, miscarriage 
and disrupted sexual development of  the offspring. It leads to temporary sterility in 
mouse-like rodents when used in the dose of  (30-50 µg/g) when ingested at the age 
of  28-days. 
Human lymphocyte culture
Human lymphocyte cells were cultured according to Evans and O’Riordan [13]. 
Blood samples (5-10 ml) are normally taken from a female donor, 20-25 years old, 
by venipuncture using a 10-20 ml sterile syringe. The blood is then immediately 
transferred to a suitable sized sterile tube containing lithium heparin at concentrations 
of  100 IU/ml of  blood. The cultures were seeded immediately after the blood was 
taken in sterile 20 ml vials.
Acta Veterinaria-Beograd 2019, 69 (4), 426-433
428
Cells were cultured in Parker 199 medium supplemented with fetal calf  serum. In 30-
ml sterile vials 0.8 ml of  whole blood is added to 10 ml of  culture medium. 
The pH of  the nutrient medium was maintained at 6.8-7.2 by addition of  bicarbonate 
buffer. To minimize the risk of  culture contamination, 100 IU / ml Penicillin and 
Streptomycin were added to the medium.
Phytohemagglutinin-PHA was used to initiate lymphocytes mitotic divisions, otherwise 
stopped in the Go phase. Immediately after the addition of  PHA, 7.5 µg/g, 15 µg/g 
and 30 µg/g of  mestranol were added to the cultures.
The culture vials were placed in the incubator at 37 °C for 72 h. During the last 3 h 
prior to harvesting the cells, a spindle inhibitor colchicine (Merck) was added to the 
culture at a volume that provided a fi nal concentration of  0.5 mg / ml to block the 
spindle, providing suffi cient metaphase cells for chromosomal analysis.
Chromosome analyses were performed in cells marked in Carman solution and diluted 
in 0.56% KCl. [12].
To study the genotoxicity of  mestranol, human lymphocytes were exposed to 7.5, 
15 and 30 µg/g of  mestranol in the cell culture for three days. The mitotic activity 
of  the lymphocytes and the occurrence of  numerical and structural aberrations were 
assessed.
Statistical analysis
The results obtained were analyzed with Student’s t-test (Statgraphics 5.0-Statistical 
Graphics Corporation, USA Programme).
RESULTS
The results obtained in the research into the infl uence of  mestranol in concentrations 
of  7.5, 15 and 30 µg/g of  culture on the occurrence of  numerical chromosome 
aberrations in human lymphocytes in vitro Table 1. In a three-day treatment three 
experimental and a control group of  cells were examined. In each experimental group 
96-100 metaphase fi gures were analysed, and 62 were selected from the control.
Table 1. Numerical chromosome aberrations in human lymphocytes induced by mestranol
Doses 
Numbers of  chromosomes Aneuploidy Polyploidy
<46 % 46 % >46 % No. % No. %
K 62 1 1.61 61 98.38 0 0.00 1 1.61 0 0.00
I 100 8 8.00 89 89.00 3 3.00 11 11.00 0 0.00
II 96 7 7.92 86 89.58 3 3.12 10 10.41 0 0.00
III 77 7 9.09 67 87.01 2 2.59 9 11.68 1 1.29
Tested conc.: K – control group, I – 7.5 µg/g, II – 15 µg/g, III – 30 µg/g
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In the solvent control, a diploid number of  chromosomes was detected in 98.38% of  
the cells analyzed and aneuploidy was found in 1.61%, polyploidy did not occur. In 
mestranol-treated cultures the percentage of  lymphocytes with aneuploidy was dose-
dependent: in lymphocytes treated with the maximum dose it reached 11.68%, out 
of  which the majority - 9.09% of  the total number of  examined - were with haploid 
metaphases. Along with the increase in the mestranol dose – in 15 and 30 µg/g – 
there was an increase in the number of  polyploid cells from 0.0% to 1.29%. This 
increase in the effect of  mestranol was statistically signifi cant (p<0.01). The frequency 
of  numerical aberrations in all of  the three mestranol doses was signifi cantly higher in 
comparison to the control (p<0.01), with the exception of  polyploidy, which did not 
increase signifi cantly (p>0.05).
The second part of  the research consisted of  the assessment of  structural chromosome 
aberrations in human lymphocyte cultures exposed to various doses (7.5, 15 and 30 
µg/g culture medium) of  mestranol for 72 h. The average values of  chromosomal 
damages are shown in Table 2.
Table 2. Cytogenetic damage and Robertsonian translocations in cultured human lymphocytes 
caused by mestranol
Groups
Structural chromosomal abnormalities %
Gaps Fragments Robertsonian translocations
K 0.0 1.0 0.0
I 4.0 5.5 0.0
II 10.5 10.0 1.0
III 11.0 11.0 2.0
Tested conc.: K – control gr oup, I – 7.5 µg/g, II – 15 µg/g, III – 30 µg/g
Table 3. shows the results of  chromosome aberrations produced by mestranol in human 
lymphocyte cultures. The study was performed on a control and three experimental 
groups of  human lymphocytes who were exposed to 7.5, 15 and 30 µg/g of  mestranol 
for three days. In each group 700-800 cell cultures were analyzed.
Table 3. Mitotic activity in cultured human lymphocytes treated with three doses of  mestranol
Doses Viewed mitosis Mitotic activity X Min-max
Mean deviation 
(SD)
K 700 6,6,7,6,5,4,6 5,71 4-7 0.9512
I 700 4,4,5,4,5,6,4 4,57 4-6 0.7868
II 800 3,4,4,4,3,3,4,3 3,50 3-4 0.5345
III 700 2,3,3,3,2,2,3 2,57 2-3 0.5345
Tested conc.: K – control group, I – 7.5 µg/sample, II – 15 µg/sample III – 30 µg/sample
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The control experimental group showed an average mitotic activity of  5.71 with 
more distinct individual variability, ranging from 4-7. During the treatment of  human 
lymphocytes, the mitotic activity decreased depending on the dose. The lowest mitotic 
activity of  2.57 was registered in the group which was exposed to 30 µg/g of  mestranol. 
A low individual variability was present in all experimental groups.
DISCUSSION
The research was done on three experimental groups and one control group of  
cultures. In all the groups on average 100 metaphase fi gures have been analysed. 
In the control group chromosomal gaps and fragments occurred sporadically (1%). 
Robertsonian translocations have not been noticed. With the increase in the dose, at 
the same length of  exposition, the frequency of  structural aberrations increased and 
reached its maximum at the highest dose of  mestranol (30 µg/g of  culture medium). 
The increase was dose-dependent and signifi cant (p<0.01), with the exception of  
Robertsonian translocations, which were increased signifi cantly only in cultures 
treated with the highest dose of  mestranol (30 µg/g culture medium). Statistically 
signifi cant (p<0.01) differences were noticed between doses 30 µg/g and 7.5 µg/g. 
Also, statistically signifi cant differences between the levels of  gaps and fragments, 
in comparison to Robertsonian translocations (p<0.01) were recorded, while the 
numbers of  gaps and fragments were not signifi cantly different.
In addition to this, the statistically signifi cant differences in the levels of  gaps and 
fragments are comparable to Robertsonian translocations (p<0.01), whilst the number 
of  chromosome breaks did not change signifi cantly.
Based on the results of  this research it is obvious that mestranol in the doses administered 
may do damage to the genetic material in human lymphocyte cultures exposed for 72 
h. Cytogenetic changes were recorded also due to some other rodenticides, [14-16] 
as well as in a number of  other substances in use in veterinary medicine [17-20]. The 
majority of  those researches were performed in vitro, in human lymphocyte cultures, 
[21,22] similarly to our study. Besides genotoxic effects, as a fi nal consequence to the 
genetic material, which have been detected in our research on mestranol, [23-25] this 
substance leads to infertility predominantly in male rodents, to temporary infertility in 
monkeys, but does not affect fertility in mice and hares.
CONCLUSIONS
In human peripheral blood lymphocyte cultures exposed for 72 h to various doses of  
mestranol -7.5, 15 and 30 µg/g medium, a mitotic suppression activity was noticed 
when compared to the negative control.
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Mestranol in various doses – 7.5, 15 and 30 µg/g, in a three-day treatment expressed 
a mitotic suppression activity in lymphocyte cells of  peripheral blood in vitro, in 
comparison to the control group. 
The tested chemosterilant proved capable of  producing numerical and structural 
chromosomal aberrations in human lymphocytes in vitro.
Authors’ contributions
TR coordinated the study, elaborated the experimental design, conducted the 
experiments and wrote the paper with input from all authors. DV, NN and JLj 
conducted the experiments and reviewed the manuscript. ĐS and MM analysed the 
data and reviewed the manuscript. All authors read and approved the fi nal version of  
the manuscript.
Declaration of  confl icting interests
The author(s) declared no potential confl icts of  interest with respect to the research, 
authorship, and/or publication of  this article.
REFERENCES
1. Stanimirović Z, Vučinić M, Soldatović B, Marković B: Genotoxicity and potential 
hemosterilant effects of  Rodol, Acta Vet Beograd 1997, 47: 237-246.
2. Shoupe D: The Handbook of  Contraception. A Guide for Practical Management. Springer 
Science & Business Media.. EE is about 1.7 times as potent as the same weight of  mestranol. 
2007, 23–ISBN978-1-59745-150-5.
3. Gao Y., Short R. V: The control of  rodent populations, Oxford Reviews Of  Reproductive 
Biology 1993, 15:263-310
4. Hiromichi   O,   Maki   I,   Yosuke   M,   Taishi   T, Motoshi T: Dffect of  Pasteurella multocida 
soluble antigen stimulation on the in vitro response of  peripheral blood mononuclear cells 
of  holstein calves. Acta Vet-Beograd 2018, 68(2): 201-210.
5. Stanimirović Z, Vučinić M, Soldatović B, Marković B: Genotoxicity and potential 
hemosterilant effects of  Rodol, Acta Vet Beograd 1997, 47: 237-246.
6. Kataranovski D: Citotoksični efekat antikoagulantni rodenticida na populacije vrste Rattus 
norvegicus BERK 1769 i čoveka, Magistarski rad, Centar za multidisciplinarne studije 
Univerziteta u Beogrdau 1985.
7. Sofradžija A., Hadžiselimović R, Maslić E,: Genotoksičnost pesticida, Svjetlost Sarajevo. 
1989.
8. Soldatović B, Janković D, Milosavljević S, Savić I, Kataranovski D: Dejstvo Rakumina 57 
i Rosola na hormone sivog pacova , VIII Simpozijum iz oblasti DDD, Ohrid, 1979, 4-6.
9. Soldatović B, Zimonjić D, Kataranovski D, Savić I:, Citogenetički efekti Rakumina 57 i 
DDT-a na ćelije pacova Rattus norvegicus i čoveka, Zbornik radova II Simpozijuma-DDD 
u zaštiti zdravlja ljudi, Beograd 1980, 165-168.
Acta Veterinaria-Beograd 2019, 69 (4), 426-433
432
10. Hijová E, Bertková I, Štofi lová J, Strojný L, Chmelárová A, Bomba A: Anti-infl ammatory 
potential of  Lactobacillus plantarum LS/07 in acute colitis in rats, Acta Vet-Beograd 2018, 
68(1):55-64.
11. Vučinić M: Uticaj kombinovane intragastrične aplikacije benzalkonijum-hlorida i varfarin-
natrijuma na citogenetičke promene ćelija kostne srži i semenika laboratorijskih miševa, 
Doktorska disertacija, Beograd 1994.
12. Hsu TC, Patton JI: Bone marow preparations for chromosome studies, In: Bemirschke 
K (Ed). Comparative mammalian cytogenetics, Springer Verlag, Berlin Heikdelberg New 
York 1969, 454-460.
13. Falaq N, Jyoti S, Akhtar N, Afzal M, Siddique YH: Genotoxic damage in cultured human 
peripheral blood lymphocytes of  oral contraceptive users. Egypt J Med Hum Genet 2012, 
13(3): 301-305.
14. Kataranovski D.S, Kataranovski M.V, Ivanovic, I., Mandic-Radic, S: The toxicity of  
rodenticides in rats following topical application I LD 50 and LD 100 values and changes 
of  selected serum and urine biochemical parameters. Journal-Serbian Chemical Society 
1994, 59:787-787.
15. Faigle, J.W, Schenkel, L: “Pharmacokinetics of  estrogens and progestogens”. In in Fraser; 
Ian S. Estrogens and Progestogens in Clinical Practice. London. Churchill Livingstone 
1989, 273–294. ISBN0-443-04706-5.
16. Lemke L.T,. Williams A.D: Foye’s Principles of  Medicinal Chemistry. Baltimore 2007, 
ISBN0781768799.
17. Teodorović R: Cytogenetic changes in bone marrow and fi broblast cells of  BALB/C 
laboratory mice induced by Mestranol, Acta Vet Beograd 2004, 54:263-270.
18. Falcone T,  Hurd W: Clinical Reproductive Medicine and Surgery. Elsevier Health Sciences. 
2007, 388–.ISBN0-323-03309-1.
19. Stanimirović Z, Fišter S, Stevanović J: Analysis of  sister-chromatid exchanges in cultured 
human lymphocytes treated with cymiazole hydrochloride, Acta Vet Beograd 2003,53: 419-
425.
20. Schmider J, Greenblatt D J, Moltke L, Karsov D, Hylar V R L, Friedman R I Shader: 
Biotransformation of  Mestranol to Ethinyl Estradiol In Vitro: The Role of  Cytochrome 
P-450 2C9 and Metabolic Inhibitors. The Journal of  Clinical Pharmacology 1997, 37, 3, 
193
21. Stanimirović Z, Todorović D, Stevanović J, Mladenović M., Janković Lj, Đorđević M: 
Infl uence of  cymiazole hydrochloride on mitotic and proliferative activities of  cultured 
human lymphocites, Acta Vet Beograd 2003, 53:47-55.
22. Đelić N, Spremo-Potparević B, Marković B, Živković L, Đelić D: Cell cycle kinetics and 
cytogenetic change in human lymphocites exposed to ostradiol in vitro, Acta Vet Beograd 
2006, 56: 37-48.
23. Filshie M, Guillebaud J: Contraception Science and Practice. Elsevier Science 2013, 12–
ISBN978-1-4831-6366-6.
24. Marks L: Sexual Chemistry. A History of  the Contraceptive Pill. Yale University Press. 
2012, 75–ISBN978-0-300-16791-7. 
25. Lentz M G, Lobo A R,Gershenson M D, Vern L K:Comprehensive Gynecology. Elsevier 
Health Sciences.2012, 224–.ISBN0-323-06986-X.
Teodorović et al: Chromosome aberrations produced by mestranol in human lymphocyte cultures
433
CITOGENETIČKE PROMENE U KULTURI                   
LIMFOCITA INDUKOVANE MESTRANOLOM
TEODOROVIĆ Radislava, DRAŠKOVIĆ Vladimir, ĐURIĆ Spomenka, 
NENADOVIĆ Kartarina, MIRILOVIĆ Milorad, JANKOVIĆ Ljiljana
U ovom radu su izvršena ispitivanja genotoksičnih svojstava mestranola u različitim 
dozama: 7,5, 15 i 30 µg/g kulture ćelija – humanih limfocita, tokom ekspozicije od 3 
dana, u uslovima “in vitro”. Procena genotoksičnih efekata  mestranola urađena je na 
osnovu numeričkih i strukturnih aberacija u tri eksperimentalne grupe sa po jednom 
kontrolnom za svaku dozu. Na osnovu rezultata naših ispitivanja može se zaključiti 
da mestranol u testiranim dozama dovodi do genotoksičnih efekata na  limfocitima 
čoveka. Broj numeričkih aberacija se povećavao sa rastom doze i  statističkom anal-
izom su utvrđene signifi kantne razlike (<0,01) u odnosu na kontrolne grupe, ali ne 
i između primenjenih doza (>0,05). U slučaju poliploidija nije utvrđena statistički 
značajna razlika u odnosu na kontrolnu grupu (>0,05). Analizirajući dobijene rezultate 
utvrđeno je da sa povećanjem doze pri istoj ekspoziciji dolazi do statistički značajnog 
(<0,01) povećanja broja strukturnih aberacija na limfocitima, pri čemu najviši nivo 
je postignut kod najviše primenjene doze (30 µg/g c.c.). Kada su u pitanju Robert-
sonove translokacije statistička značajnost u odnosu na kontrolnu grupu utvrđena je 
tek kod najviše primenjene doze (30 µg/g c.c.). Statistički značajne razlike (p<0,01) 
su zabeležene između doza od 30 µg/g c.c i 7,5 µg/g c.c. Takođe statistički značajne 
razlike između nivoa otvora i fragmenata mogu se uporediti sa Robertsonovim trans-
lokacijama (p<0,01), dok se broj otvora fragmenata neće značajno promeniti.
